Physician profile
Robert Caiati
NPI 1881891612
$5,106.97
in general payments reported to CMS, 2019-2025
15 companies · $735 in 2025
The $735 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $110 · 2021: $1,057 · 2022: $1,590 · 2023: $745 · 2024: $681 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,011 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,010.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,850.57 | 2019-2022 | |
| Abbvie INC. | $1,434.07 | 2023-2025 | Botox |
| Merz North America, INC. | $1,141.09 | 2022-2023 | Xeomin |
| Galderma Laboratories, L.P. | $199.82 | 2019-2021 | |
| Lilly USA, LLC | $83.98 | 2022-2023 | Mounjaro |
| Daiichi Sankyo INC. | $80.36 | 2022-2023 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $65.49 | 2023-2024 | Breztri, Airsupra |
| Novartis Pharmaceuticals Corporation | $58.91 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.62 | 2022-2023 | Trulance, Xifaxan |
| Idorsia Pharmaceuticals US INC | $42.94 | 2023 | Quviviq |
| Novo Nordisk INC | $27.85 | 2022 | |
| Exact Sciences Corporation | $22.93 | 2023 | Cologuard Collection Kit |
| Acerus Pharmaceuticals Corporation | $19.26 | 2022 | |
| Almatica Pharma LLC | $14.97 | 2023 | Sertraline Hcl, Gralise, Loreev Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Caiati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.